BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21972226)

  • 1. Development and validation of a prognostic nomogram for terminally ill cancer patients.
    Feliu J; Jiménez-Gordo AM; Madero R; Rodríguez-Aizcorbe JR; Espinosa E; Castro J; Acedo JD; Martínez B; Alonso-Babarro A; Molina R; Cámara JC; García-Paredes ML; González-Barón M
    J Natl Cancer Inst; 2011 Nov; 103(21):1613-20. PubMed ID: 21972226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system.
    Mariani L; Miceli R; Kattan MW; Brennan MF; Colecchia M; Fiore M; Casali PG; Gronchi A
    Cancer; 2005 Jan; 103(2):402-8. PubMed ID: 15578681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a prognostic scale for use in patients with advanced cancer.
    Stone P; Kelly L; Head R; White S
    Palliat Med; 2008 Sep; 22(6):711-7. PubMed ID: 18715969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer.
    Kattan MW; Gönen M; Jarnagin WR; DeMatteo R; D'Angelica M; Weiser M; Blumgart LH; Fong Y
    Ann Surg; 2008 Feb; 247(2):282-7. PubMed ID: 18216534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.
    Rouzier R; Pusztai L; Delaloge S; Gonzalez-Angulo AM; Andre F; Hess KR; Buzdar AU; Garbay JR; Spielmann M; Mathieu MC; Symmans WF; Wagner P; Atallah D; Valero V; Berry DA; Hortobagyi GN
    J Clin Oncol; 2005 Nov; 23(33):8331-9. PubMed ID: 16293864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
    Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI
    J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study.
    Suh SY; Ahn HY
    Eur J Cancer; 2007 Apr; 43(6):1051-9. PubMed ID: 17349786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
    J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer.
    Svatek R; Karakiewicz PI; Shulman M; Karam J; Perrotte P; Benaim E
    Eur Urol; 2006 Apr; 49(4):666-74. PubMed ID: 16423446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma.
    Cho CS; Gonen M; Shia J; Kattan MW; Klimstra DS; Jarnagin WR; D'Angelica MI; Blumgart LH; DeMatteo RP
    J Am Coll Surg; 2008 Feb; 206(2):281-91. PubMed ID: 18222381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.
    Chi DS; Palayekar MJ; Sonoda Y; Abu-Rustum NR; Awtrey CS; Huh J; Eisenhauer EL; Barakat RR; Kattan MW
    Gynecol Oncol; 2008 Jan; 108(1):191-4. PubMed ID: 17950784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative performance status, heart rate and respiratory rate as predictive factors of survival time in terminally ill cancer patients.
    de Miguel Sánchez C; Elustondo SG; Estirado A; Sánchez FV; de la Rasilla Cooper CG; Romero AL; Otero A; Olmos LG
    J Pain Symptom Manage; 2006 Jun; 31(6):485-92. PubMed ID: 16793488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
    Kattan MW; Shariat SF; Andrews B; Zhu K; Canto E; Matsumoto K; Muramoto M; Scardino PT; Ohori M; Wheeler TM; Slawin KM
    J Clin Oncol; 2003 Oct; 21(19):3573-9. PubMed ID: 12913106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a nomogram for predicting outcome of patients with vulvar cancer.
    Rouzier R; Preti M; Haddad B; Martin M; Micheletti L; Paniel BJ
    Obstet Gynecol; 2006 Mar; 107(3):672-7. PubMed ID: 16507940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
    Saisho T; Okusaka T; Ueno H; Morizane C; Okada S
    Hepatogastroenterology; 2005; 52(66):1654-8. PubMed ID: 16334750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality.
    Eilber FC; Brennan MF; Eilber FR; Dry SM; Singer S; Kattan MW
    Cancer; 2004 Nov; 101(10):2270-5. PubMed ID: 15484214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients.
    Hupertan V; Roupret M; Poisson JF; Chretien Y; Dufour B; Thiounn N; Mejean A
    Cancer; 2006 Dec; 107(11):2604-8. PubMed ID: 17075871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
    J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum lactate dehydrogenase and CD4+/CD8+ lymphocyte ratio predict survival in terminally ill cancer patients].
    Ohara T; Takahashi M; Yamanaka H; Yamamoto Y; Shimada A; Nakaho T
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1779-83. PubMed ID: 12402429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system.
    Wong SL; Kattan MW; McMasters KM; Coit DG
    Ann Surg Oncol; 2005 Apr; 12(4):282-8. PubMed ID: 15827679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.